今开:0.0 | 昨收:11.83 |
最高:0.0 | 最低:0.0 |
涨停价:0.0 | 跌停价:0.0 |
总市值:6.21202587E8 |
chuminhua2023-01-31 12:19
1月30日,FDA 宣布批准 Stemline Therapeutics $Stemline医疗(STML)$ 的 口服选择性雌激素受体降解剂(SERD)Orserdu(elacestrant)用于患有 ER+/HER2-、ESR1 突变的晚期或转移性乳腺癌且在至少一种内分泌治疗后疾病进展的绝经后女性或成年男性。 该机构去年给与该申请优先审评。网页链接查看全文
牛唐2020-01-16 21:55
研发类药企商业化任重道远,成功概率小,多半是好药在手,难以销售$Portola制药(PTLA)$ $Stemline医疗(STML)$ 就是这个道理。$欢聚时代(YY)$查看全文
$STEMLINE THERAPEUTICS INC(STML)$ 10-Q - Quarterly report [Sections 13 or 15(d)] Filed: 2016-08-08 AccNo: 0001104659-16-137902 Size: 5 MB 网页链接
$STEMLINE THERAPEUTICS INC(STML)$ 8-K - Current report Filed: 2016-08-04 AccNo: 0001104659-16-137058 Size: 163 KBItem 2.02: Results of Operations and Financial ConditionItem 9.01: Financial Statements and Exhibits 网页链接
$STEMLINE THERAPEUTICS INC(STML)$ 8-K - Current report Filed: 2016-06-06 AccNo: 0001104659-16-125664 Size: 111 KBItem 8.01: Other Events 网页链接
$STEMLINE THERAPEUTICS INC(STML)$ S-8 - Securities to be offered to employees in employee benefit plans Filed: 2016-06-02 AccNo: 0001104659-16-125122 Size: 126 KB 网页链接
$STEMLINE THERAPEUTICS INC(STML)$ 8-K - Current report Filed: 2016-05-25 AccNo: 0001104659-16-123339 Size: 34 KBItem 5.07: Submission of Matters to a Vote of Security Holders 网页链接
$STEMLINE THERAPEUTICS INC(STML)$ SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals Filed: 2016-05-09 AccNo: 0000038777-16-000519 Size: 234 KB 网页链接
$STEMLINE THERAPEUTICS INC(STML)$ 8-K - Current report Filed: 2016-05-09 AccNo: 0001104659-16-119221 Size: 108 KBItem 2.02: Results of Operations and Financial ConditionItem 9.01: Financial Statements and Exhibits 网页链接
$STEMLINE THERAPEUTICS INC(STML)$ 10-Q - Quarterly report [Sections 13 or 15(d)] Filed: 2016-05-09 AccNo: 0001104659-16-119264 Size: 5 MB 网页链接
$STEMLINE THERAPEUTICS INC(STML)$ 美东时间 2016-05-25 10:00 Stemline Therapeutics Inc Annual Shareholders Meeting 网页链接
$STEMLINE THERAPEUTICS INC(STML)$ DEF 14A - Other definitive proxy statements Filed: 2016-04-08 AccNo: 0001047469-16-012041 Size: 1 MB 网页链接